NEUTRISCI ANNOUNCES INITIAL ORDER FROM CRYOPHARM
VANCOUVER, British Columbia, June 19, 2019 (GLOBE NEWSWIRE) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the [...]
NEUTRISCI ANNOUNCES PRODUCT SALES INCREASE
Vancouver, British Columbia – February 26, 2019 – Neutrisci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]
NEUTRISCI PROVIDES UPDATE ON PATENT PENDING TECHNOLOGY
VANCOUVER, British Columbia, June 04, 2018 (GLOBE NEWSWIRE) – NeutriSci International Inc. (“NeutriSci”) (TSX-V:NU) (OTCQB:NRXCF) (FRANKFURT:1N9) the innovator and pioneer [...]
NEUTRISCI FILES PATENT APPLICATION
Vancouver, British Columbia – March 1, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and [...]
NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT
Vancouver, British Columbia – February 26th, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, OTCQB: NRXCF, Frankfurt: 1N9) and Lexaria [...]
NEUTRISCI ANNOUNCES A MAJOR R&D MOU WITH SCIENTUS PHARMA TO DEVELOP A MEDICAL CANNABINOID RETAIL PRODUCT
Vancouver, British Columbia – January 8, 2018 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and [...]
NEUTRISCI ANNOUNCES PENDING APPROVAL FROM JAPANESE GOVERNMENT FOR DISTRIBUTION OF CBD PRODUCTS THROUGH NATURALLY SPLENDID
VANCOUVER, BC – (Marketwired – November 06, 2017) – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: [...]